|
HS Code |
231962 |
As an accredited 3-Fluoro-4-Bromophenylacetonitrile factory, we enforce strict quality protocols—every batch undergoes rigorous testing to ensure consistent efficacy and safety standards.
| Packing | |
| Shipping | |
| Storage |
Competitive 3-Fluoro-4-Bromophenylacetonitrile prices that fit your budget—flexible terms and customized quotes for every order.
For samples, pricing, or more information, please call us at +8615371019725 or mail to admin@sinochem-nanjing.com.
We will respond to you as soon as possible.
Tel: +8615371019725
Email: admin@sinochem-nanjing.com
Flexible payment, competitive price, premium service - Inquire now!
Stepping into the lab early on a Monday, there’s always a moment where I look at my project lineup and reach for the raw materials. For those in pharmaceutical or agrochemical development, few ingredients give more flexibility than a halogenated acetonitrile, and 3-Fluoro-4-Bromophenylacetonitrile quickly grabbed my attention. Chasing efficiency, precision, and safety are the rituals that underpin modern bench work, and this compound checks those boxes in ways both subtle and significant.
Looking at this molecule, you don’t just see atoms on a whiteboard. You feel the balance of its design: a phenyl ring, decorated with a fluorine at the 3-position and a bromine at the 4, connected to an acetonitrile group. It’s a mouthful, but each piece carries purpose. Adding a fluorine atom alters electronic distribution, giving the molecule a thumbprint that sets it apart in cross-coupling reactions and nucleophilic substitutions compared to its non-fluorinated relatives. The bromine, large and electron-rich, provides another handle for reaction. In a world where selectivity can make or break a synthesis, every tweak on the ring matters. I’ve found that the combined presence of these two halogens simplifies late-stage functionalization. These details have saved me time and minimized headaches in scale-up, which speaks directly to the everyday stress that haunts development chemists.
3-Fluoro-4-Bromophenylacetonitrile lands in the form of a white-to-off-white crystalline powder. Purity matters — not for marketing slogans, but because side-products can sabotage your downstream reactions. I remember puzzling through a batch with lower than expected yield, only to trace it back to insufficient purification at this stage. Reliable vendors will specify a purity of >98%. This makes a difference not only for analytical consistency, but for reducing the time and resources spent cleaning up unwanted byproducts later.
Molecular weight falls at 230.02 g/mol. For practical folks running retrosynthetic analysis or gram-scale preparations, knowing this number off the top of your head helps with dosing, calculations, and even storage planning. The acetonitrile group’s presence means this compound brings added reactivity, often acting as a handle for further transformations like alkylations, reductions, or condensations. I’ve leaned on this flexibility when projects took an unexpected turn — it pays to keep options open.
Let’s get into what makes 3-Fluoro-4-Bromophenylacetonitrile more than just a name in a catalog. If you’re workshopping molecules for a next-generation herbicide or a drug lead, tweaked arylacetonitriles like this one can form the core of your skeleton. They fit into cross-coupling reactions, including Suzuki or Buchwald–Hartwig aminations, and you’ll find the bromine’s position and reactivity to be especially handy for those palladium-catalyzed couplings. The fluorine atom’s electronegativity not only reshapes the molecule’s reactivity, but impacts the biological activity of the end product — for example, mediating metabolic stability in pharmaceutical candidates.
One lesson comes from missed yield targets. With some bromophenylacetonitriles, electronic effects don’t always play in your favor, leading to sluggish or incomplete reactions. I’ve encountered less mixed success when using the standard 4-bromo analogue in Suzuki couplings and found that swapping in the 3-fluoro version led to more predictable conversion rates and cleaner products. That evolution toward greater predictability is never trivial, especially as the project gets closer to pilot scale.
It’s tempting to think substituting positions on an aromatic ring is minor, but anyone who's run a dozen control reactions will tell you otherwise. 4-Bromophenylacetonitrile, for instance, might be considered the “default” for certain transformations, but adding a fluorine atom at the ortho position (in this case, the 3-position relative to acetonitrile) tamps down electronic resonance, altering both reactivity and physical properties. For example, the melting point often shifts slightly, providing minor but impactful changes in handling and storage.
There are other analogs—3-chloro-4-bromophenylacetonitrile, 3-nitro substitutions, or even 3,5-dibromo versions. Each brings distinct electronic and steric effects. Fluorine’s unique role as a hydrogen mimic but with greater electronegativity bridges structure and function differently than chlorine or nitro groups. In medicinal chemistry, this can lead to shifts in binding affinity or metabolic profile, something that has shown up in my own work screening analogs against enzymatic targets.
The story here is about utility. I’ve witnessed a project flounder because the chosen intermediate just wouldn’t cooperate under the reaction conditions needed for the next step, only to turn a corner after switching to a closely related fluorinated analog. It’s not just bench folklore; there’s published data showing that fluorine substitution often improves metabolic stability by blocking sites of oxidative degradation. For anyone hoping to balance synthetic flexibility with biological relevance, that’s non-trivial.
Inside medicinal chemistry, selectively halogenated phenylacetonitriles pave the way to central nervous system agents, kinase inhibitors, and antiviral scaffolds. Envision projects like the pursuit of small-molecule leads for cancer or infectious diseases. Medicinal chemists crave ways to block metabolism at vulnerable aromatic sites, and a 3-fluoro substitution can make a compound less prone to CYP450-mediated oxidation. Biological relevance always ties back to structure; implementing these analogs is rarely a shot in the dark.
Agricultural scientists find their place for such compounds, too, as precursors in newer herbicide, fungicide, or insecticide leads. Given rising concerns about resistance and environmental persistence, even minor modifications to core chemicals can extend a product’s effective lifespan. The same structure–activity reasoning applies: more stable bonds, more selective action, less off-target environmental burden.
Process chemists might take an interest for another reason. Scale-up favors intermediates that offer predictable behavior under varied conditions. 3-Fluoro-4-Bromophenylacetonitrile handles basic purification protocols with ease — filtration, crystallization, and chromatography don’t throw surprises, which reduces manufacturing risk. I’ve spent anxious days monitoring columns for analogs that streak, tail, or break down. This compound’s stability means those anxieties show up less often.
What does daily handling look like? Nobody wants a material that clumps or absorbs atmospheric moisture on opening, especially in humid climates. I’ve noted that this compound, stored in a tightly sealed bottle, sits stable for months. Standard storage at room temperature works fine — extended refrigeration hasn’t offered added value in my experience unless ultra-purity matters for parallel projects.
Solubility is usually acceptable in polar aprotic solvents. I’ve mixed batches in DMF, DMSO, and acetonitrile with predictable results, a plus for high-throughput teams standardizing their prep. The crystalline powder doesn’t tend to cake or create inhalable dust clouds, which improves both safety and workflow. Every chemist knows a horror story about a bottle that turns opening into a health hazard — this isn’t that material.
Shelf life links closely to purity. Impurities can catalyze unwanted degradation, so accurate analysis up front saves time and prevents surprises down the road. From my bench experience, batches remain stable and unchanged through standard use, which can’t always be said for less robust analogs.
Another point for consideration: as green chemistry guidance moves from advisory to expected practice, intermediates that reduce waste, energy use, or hazardous byproducts move up the wish list. 3-Fluoro-4-Bromophenylacetonitrile, thanks to its reactivity profile, streamlines synthesis for certain pharmaceutical intermediates, shrinking the number of required steps and the volume of reagents like palladium, phosphine ligands, or caustic bases.
From reacting in “greener” solvents or leveraging flow chemistry, compounds like this accommodate process innovation. I saw a team reduce their solvent waste by a third just by swapping out the less selective non-fluorinated analogue. Not every project faces that luck, but it underscores the compound’s potential contribution to environmental stewardship.
While regulatory agencies grow sharper in evaluating environmental persistence, the presence of fluorine in industrial chemicals always bears scrutiny, given the growing concern around persistent organic pollutants. Any development plan should model environmental fate and, where possible, minimize discharge. Responsible handling, comprehensive data sharing, and transparent supply chains remain crucial for building trust and meeting modern compliance standards.
Economics rarely stay out of the conversation. For specialty chemicals, price varies with supplier capability, order volume, and underlying market pressure on bromine and fluorine feedstocks. Experienced chemists watch for price spikes and plan accordingly. Chemical markets can be unpredictable, especially with global disruptions, but a consistent track record from suppliers, validated by third-party lab reports, avoids the headaches that come from failed batches or failed audits.
Real-time quality verification matters: in my own workflow, I don’t just rely on vendor-provided HPLC traces. In-house NMR and LC-MS offer peace of mind and allow me to flag potential issues before they wreak havoc on multi-step syntheses. Sophisticated buyers increasingly ask for certificates of analysis, validated analytical methods, and sustainable sourcing documentation.
Customers appreciate suppliers who communicate well, provide batch-level information, and deliver on time. Even seasoned R&D teams can face weeks-long project stalls over missing documentation or shipment delays. Consistent communication and robust performance history are worth as much as high purity, in my book.
Personal protective equipment remains standard: gloves, goggles, and a lab coat. Standard ventilation suffices; I’ve not observed significant volatilization or off-gassing issues. Material safety data sheets highlight typical organohalide cautions — these compounds are handled much like other acetonitriles and aryl bromides in a research setting. For those unfamiliar, skin or inhalational exposure may cause irritation, and long-term toxicological data is sparse. I’ve never observed major incidents given common sense lab practices, but prudence always wins over bravado.
Disposal should follow local hazardous waste policies. Halogenated organics don’t belong down the sink or in general trash. Responsible teams train on proper waste segregation, and I see no reason to shortcut that diligence. If in doubt, consult with your in-house EHS specialist or waste disposal partner.
No intermediate arrives without frustration points. Supply interruptions, price increases, or purity drift can throw research progress into disarray. Teams that keep backup sources, negotiate transparency in supply, and manage relationships with multiple suppliers weather these issues more smoothly. I’ve made a habit of documenting supplier performance — not just cost, but delivery times and analytical consistency — and making adjustments based on real-world outcomes, rather than brand loyalty or habit.
Analytical bottlenecks sometimes slow things down. Investing in reliable in-house GC/MS or NMR speeds troubleshooting. Many times, caught impurities before they became expensive problems three steps later. Similarly, documenting all protocols, updating them as new challenges arise, and encouraging open communication within the team allows for rapid pivots when the inevitable chemistry surprises pop up.
In the bigger picture, staying aware of how even subtle structural differences influence both chemical reactivity and ultimate biological outcome builds insight and saves money. Chemists who take the time to compare analogs like 4-bromophenylacetonitrile, 3-chloro-4-bromophenylacetonitrile, and the present 3-fluoro-4-bromophenylacetonitrile in controlled reactions end up making more informed decisions. Over time, those saved developments hours add up, reducing frustration and driving breakthroughs.
Ethical work in chemical sciences has never mattered more. Whether in pharmaceutical or agricultural research, transparency in compound sourcing, accuracy in analytical reporting, and respect for potential environmental impacts build trust. I’ve seen pride in teams who don’t take shortcuts, who ask tough questions about their environmental footprint and who share data — not just the positive results, but the challenging ones too. Peers, regulators, and the next generation of scientists rely on that transparency.
In an era of quick-turn research, attention to detail and verification of product integrity are hallmarks of responsible development. 3-Fluoro-4-Bromophenylacetonitrile represents a step in a longer chain; its reputation depends not only on what it can do, but on how scrupulously it gets characterized, handled, and documented. I urge fellow chemists and procurement specialists to seek evidence for supplier claims, to run control reactions, and to track the compound’s fate not only in the flask, but in downstream waste and emissions.
Through every stage of my career in synthetic and medicinal chemistry, details have ruled the day. The ambition to deliver new medicines, safer crop protection agents, or clever materials starts not with abstract targets, but with reliable, manageable building blocks. 3-Fluoro-4-Bromophenylacetonitrile emerged as one such unit — valued for its balance of ease-of-use, broad reactivity, and ability to impart unique physical or biological characteristics. For hands-on chemists, process engineers, and procurement professionals alike, its small differences unlock meaningful progress in workflow.
Looking ahead, I continue to trust in products whose performance on the bench matches their reputation in the industry. Compounds like this bring the promise of sharper, more sustainable research and sharper, more productive debates about progress and responsibility. Having benefitted from such quality firsthand, it’s clear that even behind long names and subtle modifications, there lie genuine tools that elevate both chemistry and the chemists who wield them.